Bone Turnover Measurement
Bone Turnover Measurement - Related Videos
14:27
Steady-state, Pre-steady-state, and Single-turnover Kinetic Measurement for DNA Glycosylase Activity
0 Views •
Cited by 26 •
2013
Time courses for the glycosylase activity of 8-oxoguanine DNA glycosylase are biphasic exhibiting a burst of product formation and a linear steady-state phase. Utilizing quench-flow techniques, the burst and the steady-state rates can be measured, which correspond to excision of 8-oxoguanine and release of the glycosylase from the product DNA, respectively.
08:49
Models of Bone Metastasis
0 Views •
Cited by 115 •
2012
Animal models are frequently utilized to study cancer metastasis to bone. In this protocol we will describe two common methods of tumor inoculation for bone metastasis studies and briefly describe some of the analyses utilized to monitor and quantify these models.
08:31
Measuring Membrane Lipid Turnover with the pH-sensitive Fluorescent Lipid Analog ND6
0 Views •
Cited by 2 •
2021
This protocol presents a fluorescence imaging method that uses a class of pH-sensitive lipid fluorophores to monitor lipid membrane trafficking during cell exocytosis and the endocytosis cycle.
![Quantitative [<sup>18</sup>F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58491.jpg%3Fv%3D2026-09-01%252012%253A19%253A40&w=750&q=75)
06:31
Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain
0 Views •
2019
Imaging techniques that reflect dynamic bone turnover may aid in characterizing a wide range of bone pathologies. We present detailed methodologies for performing and analyzing dynamic [18F]-NaF-PET-MRI data in a patient with facetogenic low back pain using the lumbar facet joints as a prototypical region of interest.
01:29
Analysis of Accounts Receivable Turnover
0 Views •
2025
Accounts receivable turnover is critical for evaluating how effectively a company manages its credit sales and collections. High turnover typically signals that a company collects outstanding debts promptly. In contrast, a low turnover may point to issues in credit policy or customer payment behavior that can strain cash flow and working capital.Calculating the Turnover RatioThe accounts receivable turnover ratio is calculated as:Accounts Receivable Turnover = Net Credit Sales ÷ Average...
FAQs
Bone formation markers reflect activity associated with osteoblast-mediated production of new tissue, whereas resorption markers reflect osteoclast-mediated breakdown of existing bone. Measuring these categories separately can show whether skeletal activity is more strongly associated with formation or resorption at the time of testing. That distinction helps characterize remodeling patterns in disease and treatment studies.
Considering both sides is important because bone remodeling depends on the relationship between new tissue production and old tissue removal. A result from only one marker category may not describe the overall skeletal pattern. Comparing formation and resorption information can therefore provide a more balanced assessment of skeletal activity and help investigators evaluate how that activity changes over time.
Concentrations in blood or urine provide indirect, time-sensitive estimates, so results represent current skeletal activity rather than a permanent measure of bone status. Interpretation should account for when the sample was obtained and should not treat one measurement as a complete description of long-term remodeling. This temporal limitation is especially relevant when tracking change.
Clinical or imaging assessments add information that biochemical markers cannot provide alone. Markers indicate activity through concentrations in blood or urine, while imaging or clinical assessment contributes complementary evidence about skeletal status. Combining these sources can make evaluation more informative than relying on a single measurement, particularly when assessing disease, treatment-related change, or broader skeletal health.
A typical assessment combines biochemical testing with clinical or imaging information. Blood or urine samples are used to measure markers linked to formation and resorption, while clinical or imaging assessments provide complementary context. The appropriate combination depends on the question being studied, such as characterizing a metabolic bone disorder, evaluating skeletal activity, or following a treatment response.
In clinical medicine, these measurements can support evaluation of metabolic bone disorders and help estimate changes in skeletal activity. They are also useful when clinicians need information about how bone remodeling is behaving alongside other patient characteristics. Results are most meaningful when interpreted in context rather than viewed as an isolated laboratory value.
During osteoporosis care, repeated measurements can help monitor response to treatment by showing changes in skeletal activity over time. In research, the same approach supports investigations of fracture risk and bone remodeling. These uses do not replace contextual interpretation: patient characteristics and complementary clinical or imaging findings help determine what a measured change means.